🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Arcutis Biotherapeutics, Inc.

ARQT Healthcare
$26.36 $-0.81 (-2.98%)
Market Cap: $3.33 B
Gurus Holding
4
Popularity Rank
#2675
% of Shares Held
0.80%
Net Activity (Q3 2026)
+$3 M

Guru Ownership Trend

Guru Analysis for Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics, Inc. (ARQT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $26.7 M.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Bullish. This is evidenced by a $3 M net inflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 715.3%. Conversely, Paul Tudor Jones reduced exposure by 88.4%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q3 2026)

+$15.59 M
Total Buy Value
New Buys 0
Additions 2
-$12.59 M
Total Sell Value
Reductions 2
Sold Out 1

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
3
Net Buyers
2

FAQs for Arcutis Biotherapeutics, Inc. (ARQT)

Major holders include Cliff Asness ($13.28 M), Renaissance Technologies (RenTech) ($12.58 M), Joel Greenblatt ($498,496). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.01 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $3 M, with 2 managers increasing positions and 3 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ARQT. The total reported sell value was $12.59 M.

Yes, 0 managers opened new positions in ARQT, and 2 increased their existing holdings. The total reported buy value was $15.59 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Add 52.1% 502,403 $13.28 M Q3 2026
0.02% Add 715.3% 476,099 $12.58 M Q3 2026
0.00% Reduce -0.9% 18,861 $498,496 Q3 2026
0.00% Reduce -88.4% 15,357 $405,886 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form